DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Regal Healthcare Capital Management, LLC
Regal Healthcare Capital Management, LLC
Private equity with venture activity · probableNew York, NYregalhcp.comSEC registered investment adviser
Regal Healthcare Capital Partners is a private equity investment firm investing in lower and middle market companies in the healthcare service sector.
registered adviser; venture funds are 0% of 5 private funds
Importance
31
moderate
Active deployment
4
low
Emerging
0
low
Completeness
69
high
Freshness
100
high
Research priority
6
low
Identity and regulatory footprint
- Headquarters
- New York, NYadviserinfo.sec.gov
- Office address
- ONE PENN PLAZA, SUITE 4610, New York, NY, 10119adviserinfo.sec.gov
- Business phone
- (212)-393-4790adviserinfo.sec.gov
- Website
- HTTPS://WWW.REGALHCP.COM/
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Mar 27, 2024
- Private funds reported
- 5 (0 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $704Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $704Mthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 19
- business phone
- (212)-393-4790adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- healthcare
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- $30.0M to $70.0M stated by the firm
“Equity Investment of $30- 70M”
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 1
Funds and vehicles
3 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Rhcp-Ii, L.P. | Fund · ADV: Private Equity Fund | 2019 form d first sale | Mature | $83.8M Mar 27, 2024 | 81 | $83.6M of $83.6M | Aug 8, 2019 |
| Rhcp-Ii Qp, L.P. | Feeder or parallel · ADV: Private Equity Fund | 2019 form d first sale | Mature | $81.9M Mar 27, 2024 | 5 | $82.3M of $82.3M | Aug 8, 2019 |
| Regal Healthcare Capital Partners, L.P. | Fund · ADV: Private Equity Fund | 2018 form d first sale | Harvest | $131M Mar 27, 2024 | 79 | $58.3M of $100M | Mar 2, 2018 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
28 current, 1 departed
Daniel Lowe
AnalystAnalyst
Kate Von Dohlen
AnalystAnalyst
Allegra Giordano
AssociateAssociate
David Wassef
AssociateAssociate
Isaki Wada-Law
AssociateAssociate
Kelsey Corwen
AssociateAssociate
Melissa Li
AssociateAssociate
Founder or executive
Surinder Sandhu
Founder or executiveCo-Founder
David Kim
General partnerCo-Founder & General Partner
Jon Santemma
General partnerCo-Founder & General Partner
David Charls Kim
Managing partnerCo-Managing Member · since Feb 1, 2018
Justin Leavitt
Operating partnerCFO Operating Partner
Anshul Debuka
OtherLead Payor Strategist
Curt Spall
OtherTech/IT Strategist
Mark Blankenship
OtherLead RCM Strategist
Domenico Nicolia
PartnerPartner
Terry K Wang
PartnerMember · since Jan 1, 2022
Terry Wang
PartnerPartner
Blair Durst
Platform and operationsGeneral Counsel
JON Ernest Santemma
Platform and operationsChief Compliance Officer · since Feb 1, 2018
Stephen Bruestle
Platform and operationsController
Kevin Yu
PrincipalPrincipal
David Carratu
Vice presidentSenior Associate
Dylan Missry
Vice presidentSenior Associate
Harry Clifford
Vice presidentVice President
Patryk Wadolowski
Vice presidentVice President
Russell Piekarsky
Vice presidentVice President
1 departed (kept with end dates)
- Jon Santemma · Co-Founder & General Partner · ? to Sep 16, 2026 Inference
Investments on record
1 edges, 1 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| One of One Brands | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
6 dated events
- Sep 16, 2026Jon Santemma (Co-Founder & General Partner) no longer on the team page of Regal Healthcare Capital Management, LLCPerson leftPeopleInferenceJon SantemmaVenture organization websites (about, team, portfolio, thesis, news pages)
- Jan 1, 2022Terry K Wang joined Schedule A of Regal Healthcare Capital Management, LLC as Member
- Mar 30, 2020Rhcp-Ii, L.P. first reported on Form ADV by Regal Healthcare Capital Management, LLC (Private Equity Fund), GAV $83,730,667Fund first reported on Form ADVFundsFactRhcp-Ii, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2020Rhcp-Ii Qp, L.P. first reported on Form ADV by Regal Healthcare Capital Management, LLC (Private Equity Fund), GAV $82,499,333Fund first reported on Form ADVFundsFactRhcp-Ii Qp, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 16, 2018Regal Healthcare Capital Management, LLC first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 16, 2018Regal Healthcare Capital Partners, L.P. first reported on Form ADV by Regal Healthcare Capital Management, LLC (Private Equity Fund), GAV $75,000,000Fund first reported on Form ADVFundsFactRegal Healthcare Capital Partners, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 0% of 5 private funds
Evidence
41 observations from 2 sources